APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Vaccine

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

Selected research

Market Analysis & Forecast

Global Human Vaccine Market Analysis and Forecast 2026-2032

21 December 2025217 pages

Choose your research edition.

Industry ResearchHuman Vaccine Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Vaccine Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Human Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Vaccine Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Vaccine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.

East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.

Read the full market overview

In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.

This report presents an overview of global market for Human Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Human Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Vaccine sales, projected growth trends, production technology, application and end-user industry.

Human Vaccine Segment by Company

CNBG

Changsheng Life

Zhifei

ChengDa Bio

Kangtai

SINOVAC BIOTECH

Hissen

Walvax Biotechnology

GSK

SANOFI

Rong An

NuoCheng Bio

Hualan Bio

Tiantan biological

Changchun Baike

Adimmune

Zhongyianke Biotech

Bharat Biotech

Bavarian Nordic

Sanofi-Pasteur

Indian Immunologicals

KANGH

Henan Grand Biopharma

ZhongKe Biopharm

Zhuoyi Biological

Human Vaccine Segment by Type

Varicella

Influenza

Polio

Hepatitis A

Rabies

BCG

Hepatitis B

Pertussis, Diphtheria, Tetanus

Pneumococcal

Rota vaccine

Human Vaccine Segment by Application

Adults

Children

Human Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Varicella Major Manufacturers Table 3. Influenza Major Manufacturers Table 4. Polio Major Manufacturers Table 5. Hepatitis A Major Manufacturers Table 6. Rabies Major Manufacturers Table 7. BCG Major Manufacturers Table 8. Hepatitis B Major Manufacturers Table 9. Pertussis, Diphtheria, Tetanus Major Manufacturers Table 10. Pneumococcal Major Manufacturers Table 11. Rota vaccine Major Manufacturers Table 12. Global Human Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 13. Adults Major Manufacturers Table 14. Children Major Manufacturers Table 15. Human Vaccine Industry Trends Table 16. Human Vaccine Industry Drivers Table 17. Human Vaccine Industry Opportunities and Challenges Table 18. Human Vaccine Industry Restraints Table 19. Global Human Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Human Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Human Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Human Vaccine Revenue Market Share by Region (2021-2026) Table 23. Global Human Vaccine Revenue Market Share by Region (2027-2032) Table 24. Global Human Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 25. Global Human Vaccine Sales by Region (2021-2026) & (M Doses) Table 26. Global Human Vaccine Sales by Region (2027-2032) & (M Doses) Table 27. Global Human Vaccine Sales Market Share by Region (2021-2026) Table 28. Global Human Vaccine Sales Market Share by Region (2027-2032) Table 29. Global Human Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Human Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Human Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Human Vaccine Sales Market Share by Manufacturers (2021-2026) Table 33. Global Human Vaccine Sales Price (USD/Dose) of Manufacturers (2021-2026) Table 34. Global Human Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Human Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Human Vaccine Manufacturers, Product Type & Application Table 37. Global Human Vaccine Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Human Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Human Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Human Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Human Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Human Vaccine Revenue Market Share by Type (2021-2026) Table 44. Global Human Vaccine Revenue Market Share by Type (2027-2032) Table 45. Global Human Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 46. Global Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 47. Global Human Vaccine Sales by Type (2027-2032) & (M Doses) Table 48. Global Human Vaccine Sales Market Share by Type (2021-2026) Table 49. Global Human Vaccine Sales Market Share by Type (2027-2032) Table 50. Global Human Vaccine Price by Type (2021-2026) & (USD/Dose) Table 51. Global Human Vaccine Price by Type (2027-2032) & (USD/Dose) Table 52. Global Human Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Human Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Human Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Human Vaccine Revenue Market Share by Application (2021-2026) Table 56. Global Human Vaccine Revenue Market Share by Application (2027-2032) Table 57. Global Human Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 58. Global Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 59. Global Human Vaccine Sales by Application (2027-2032) & (M Doses) Table 60. Global Human Vaccine Sales Market Share by Application (2021-2026) Table 61. Global Human Vaccine Sales Market Share by Application (2027-2032) Table 62. Global Human Vaccine Price by Application (2021-2026) & (USD/Dose) Table 63. Global Human Vaccine Price by Application (2027-2032) & (USD/Dose) Table 64. CNBG Company Information Table 65. CNBG Business Overview Table 66. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 67. CNBG Human Vaccine Product Portfolio Table 68. CNBG Recent Development Table 69. Changsheng Life Company Information Table 70. Changsheng Life Business Overview Table 71. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 72. Changsheng Life Human Vaccine Product Portfolio Table 73. Changsheng Life Recent Development Table 74. Zhifei Company Information Table 75. Zhifei Business Overview Table 76. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 77. Zhifei Human Vaccine Product Portfolio Table 78. Zhifei Recent Development Table 79. ChengDa Bio Company Information Table 80. ChengDa Bio Business Overview Table 81. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 82. ChengDa Bio Human Vaccine Product Portfolio Table 83. ChengDa Bio Recent Development Table 84. Kangtai Company Information Table 85. Kangtai Business Overview Table 86. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 87. Kangtai Human Vaccine Product Portfolio Table 88. Kangtai Recent Development Table 89. SINOVAC BIOTECH Company Information Table 90. SINOVAC BIOTECH Business Overview Table 91. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 92. SINOVAC BIOTECH Human Vaccine Product Portfolio Table 93. SINOVAC BIOTECH Recent Development Table 94. Hissen Company Information Table 95. Hissen Business Overview Table 96. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 97. Hissen Human Vaccine Product Portfolio Table 98. Hissen Recent Development Table 99. Walvax Biotechnology Company Information Table 100. Walvax Biotechnology Business Overview Table 101. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 102. Walvax Biotechnology Human Vaccine Product Portfolio Table 103. Walvax Biotechnology Recent Development Table 104. GSK Company Information Table 105. GSK Business Overview Table 106. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 107. GSK Human Vaccine Product Portfolio Table 108. GSK Recent Development Table 109. SANOFI Company Information Table 110. SANOFI Business Overview Table 111. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 112. SANOFI Human Vaccine Product Portfolio Table 113. SANOFI Recent Development Table 114. Rong An Company Information Table 115. Rong An Business Overview Table 116. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 117. Rong An Human Vaccine Product Portfolio Table 118. Rong An Recent Development Table 119. NuoCheng Bio Company Information Table 120. NuoCheng Bio Business Overview Table 121. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 122. NuoCheng Bio Human Vaccine Product Portfolio Table 123. NuoCheng Bio Recent Development Table 124. Hualan Bio Company Information Table 125. Hualan Bio Business Overview Table 126. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 127. Hualan Bio Human Vaccine Product Portfolio Table 128. Hualan Bio Recent Development Table 129. Tiantan biological Company Information Table 130. Tiantan biological Business Overview Table 131. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 132. Tiantan biological Human Vaccine Product Portfolio Table 133. Tiantan biological Recent Development Table 134. Changchun Baike Company Information Table 135. Changchun Baike Business Overview Table 136. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 137. Changchun Baike Human Vaccine Product Portfolio Table 138. Changchun Baike Recent Development Table 139. Adimmune Company Information Table 140. Adimmune Business Overview Table 141. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 142. Adimmune Human Vaccine Product Portfolio Table 143. Adimmune Recent Development Table 144. Zhongyianke Biotech Company Information Table 145. Zhongyianke Biotech Business Overview Table 146. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 147. Zhongyianke Biotech Human Vaccine Product Portfolio Table 148. Zhongyianke Biotech Recent Development Table 149. Bharat Biotech Company Information Table 150. Bharat Biotech Business Overview Table 151. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 152. Bharat Biotech Human Vaccine Product Portfolio Table 153. Bharat Biotech Recent Development Table 154. Bavarian Nordic Company Information Table 155. Bavarian Nordic Business Overview Table 156. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 157. Bavarian Nordic Human Vaccine Product Portfolio Table 158. Bavarian Nordic Recent Development Table 159. Sanofi-Pasteur Company Information Table 160. Sanofi-Pasteur Business Overview Table 161. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 162. Sanofi-Pasteur Human Vaccine Product Portfolio Table 163. Sanofi-Pasteur Recent Development Table 164. Indian Immunologicals Company Information Table 165. Indian Immunologicals Business Overview Table 166. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 167. Indian Immunologicals Human Vaccine Product Portfolio Table 168. Indian Immunologicals Recent Development Table 169. KANGH Company Information Table 170. KANGH Business Overview Table 171. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 172. KANGH Human Vaccine Product Portfolio Table 173. KANGH Recent Development Table 174. Henan Grand Biopharma Company Information Table 175. Henan Grand Biopharma Business Overview Table 176. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 177. Henan Grand Biopharma Human Vaccine Product Portfolio Table 178. Henan Grand Biopharma Recent Development Table 179. ZhongKe Biopharm Company Information Table 180. ZhongKe Biopharm Business Overview Table 181. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 182. ZhongKe Biopharm Human Vaccine Product Portfolio Table 183. ZhongKe Biopharm Recent Development Table 184. Zhuoyi Biological Company Information Table 185. Zhuoyi Biological Business Overview Table 186. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 187. Zhuoyi Biological Human Vaccine Product Portfolio Table 188. Zhuoyi Biological Recent Development Table 189. North America Human Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 190. North America Human Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 191. North America Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 192. North America Human Vaccine Sales by Type (2027-2032) & (M Doses) Table 193. North America Human Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 194. North America Human Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 195. North America Human Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 196. North America Human Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 197. North America Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 198. North America Human Vaccine Sales by Application (2027-2032) & (M Doses) Table 199. North America Human Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 200. North America Human Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 201. North America Human Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. North America Human Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. North America Human Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. North America Human Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 205. North America Human Vaccine Sales by Country (2021-2026) & (M Doses) Table 206. North America Human Vaccine Sales by Country (2027-2032) & (M Doses) Table 207. North America Human Vaccine Sales Price by Country (2021-2026) & (USD/Dose) Table 208. North America Human Vaccine Sales Price by Country (2027-2032) & (USD/Dose) Table 209. United States Human Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Canada Human Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Mexico Human Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Europe Human Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 213. Europe Human Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 214. Europe Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 215. Europe Human Vaccine Sales by Type (2027-2032) & (M Doses) Table 216. Europe Human Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 217. Europe Human Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 218. Europe Human Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 219. Europe Human Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 220. Europe Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 221. Europe Human Vaccine Sales by Application (2027-2032) & (M Doses) Table 222. Europe Human Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 223. Europe Human Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 224. Europe Human Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Europe Human Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Europe Human Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Europe Human Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 228. Europe Human Vaccine Sales by Country (2021-2026) & (M Doses) Table 229. Europe Human Vaccine Sales by Country (2027-2032) & (M Doses) Table 230. Europe Human Vaccine Sales Price by Country (2021-2026) & (USD/Dose) Table 231. Europe Human Vaccine Sales Price by Country (2027-2032) & (USD/Dose) Table 232. Germany Human Vaccine Revenue (2021-2032) & (US$ Million) Table 233. France Human Vaccine Revenue (2021-2032) & (US$ Million) Table 234. U.K. Human Vaccine Revenue (2021-2032) & (US$ Million) Table 235. Italy Human Vaccine Revenue (2021-2032) & (US$ Million) Table 236. Russia Human Vaccine Revenue (2021-2032) & (US$ Million) Table 237. Spain Human Vaccine Revenue (2021-2032) & (US$ Million) Table 238. Netherlands Human Vaccine Revenue (2021-2032) & (US$ Million) Table 239. Switzerland Human Vaccine Revenue (2021-2032) & (US$ Million) Table 240. Sweden Human Vaccine Revenue (2021-2032) & (US$ Million) Table 241. Poland Human Vaccine Revenue (2021-2032) & (US$ Million) Table 242. China Human Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 243. China Human Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 244. China Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 245. China Human Vaccine Sales by Type (2027-2032) & (M Doses) Table 246. China Human Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 247. China Human Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 248. China Human Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 249. China Human Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 250. China Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 251. China Human Vaccine Sales by Application (2027-2032) & (M Doses) Table 252. China Human Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 253. China Human Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 254. Asia Human Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 255. Asia Human Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 256. Asia Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 257. Asia Human Vaccine Sales by Type (2027-2032) & (M Doses) Table 258. Asia Human Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 259. Asia Human Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 260. Asia Human Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 261. Asia Human Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 262. Asia Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 263. Asia Human Vaccine Sales by Application (2027-2032) & (M Doses) Table 264. Asia Human Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 265. Asia Human Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 266. Asia Human Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 267. Asia Human Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 268. Asia Human Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 269. Asia Human Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 270. Asia Human Vaccine Sales by Country (2021-2026) & (M Doses) Table 271. Asia Human Vaccine Sales by Country (2027-2032) & (M Doses) Table 272. Asia Human Vaccine Sales Price by Country (2021-2026) & (USD/Dose) Table 273. Asia Human Vaccine Sales Price by Country (2027-2032) & (USD/Dose) Table 274. Japan Human Vaccine Revenue (2021-2032) & (US$ Million) Table 275. South Korea Human Vaccine Revenue (2021-2032) & (US$ Million) Table 276. India Human Vaccine Revenue (2021-2032) & (US$ Million) Table 277. Australia Human Vaccine Revenue (2021-2032) & (US$ Million) Table 278. Taiwan Human Vaccine Revenue (2021-2032) & (US$ Million) Table 279. Southeast Asia Human Vaccine Revenue (2021-2032) & (US$ Million) Table 280. SAMEA Human Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 281. SAMEA Human Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 282. SAMEA Human Vaccine Sales by Type (2021-2026) & (M Doses) Table 283. SAMEA Human Vaccine Sales by Type (2027-2032) & (M Doses) Table 284. SAMEA Human Vaccine Sales Price by Type (2021-2026) & (USD/Dose) Table 285. SAMEA Human Vaccine Sales Price by Type (2027-2032) & (USD/Dose) Table 286. SAMEA Human Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 287. SAMEA Human Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 288. SAMEA Human Vaccine Sales by Application (2021-2026) & (M Doses) Table 289. SAMEA Human Vaccine Sales by Application (2027-2032) & (M Doses) Table 290. SAMEA Human Vaccine Sales Price by Application (2021-2026) & (USD/Dose) Table 291. SAMEA Human Vaccine Sales Price by Application (2027-2032) & (USD/Dose) Table 292. SAMEA Human Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 293. SAMEA Human Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 294. SAMEA Human Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 295. SAMEA Human Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 296. SAMEA Human Vaccine Sales by Country (2021-2026) & (M Doses) Table 297. SAMEA Human Vaccine Sales by Country (2027-2032) & (M Doses) Table 298. SAMEA Human Vaccine Sales Price by Country (2021-2026) & (USD/Dose) Table 299. SAMEA Human Vaccine Sales Price by Country (2027-2032) & (USD/Dose) Table 300. Brazil Human Vaccine Revenue (2021-2032) & (US$ Million) Table 301. Argentina Human Vaccine Revenue (2021-2032) & (US$ Million) Table 302. Chile Human Vaccine Revenue (2021-2032) & (US$ Million) Table 303. Colombia Human Vaccine Revenue (2021-2032) & (US$ Million) Table 304. Peru Human Vaccine Revenue (2021-2032) & (US$ Million) Table 305. Saudi Arabia Human Vaccine Revenue (2021-2032) & (US$ Million) Table 306. Israel Human Vaccine Revenue (2021-2032) & (US$ Million) Table 307. UAE Human Vaccine Revenue (2021-2032) & (US$ Million) Table 308. Turkey Human Vaccine Revenue (2021-2032) & (US$ Million) Table 309. Iran Human Vaccine Revenue (2021-2032) & (US$ Million) Table 310. Egypt Human Vaccine Revenue (2021-2032) & (US$ Million) Table 311. Key Raw Materials Table 312. Raw Materials Key Suppliers Table 313. Human Vaccine Distributors List Table 314. Human Vaccine Customers List Table 315. Research Programs/Design for This Report Table 316. Authors List of This Report Table 317. Secondary Sources Table 318. Primary Sources List of Figures Figure 1. Human Vaccine Image Figure 2. Global Human Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Varicella Image Figure 5. Influenza Image Figure 6. Polio Image Figure 7. Hepatitis A Image Figure 8. Rabies Image Figure 9. BCG Image Figure 10. Hepatitis B Image Figure 11. Pertussis, Diphtheria, Tetanus Image Figure 12. Pneumococcal Image Figure 13. Rota vaccine Image Figure 14. Global Human Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Human Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 16. Adults Image Figure 17. Children Image Figure 18. Global Human Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Human Vaccine Revenue (2021-2032) & (US$ Million) Figure 20. Global Human Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Human Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Human Vaccine Revenue Market Share by Region (2021-2032) Figure 23. Global Human Vaccine Sales (2021-2032) & (M Doses) Figure 24. Global Human Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 25. Global Human Vaccine Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Human Vaccine Sales YoY (2021-2032) & (M Doses) Figure 27. Europe Human Vaccine Sales YoY (2021-2032) & (M Doses) Figure 28. China Human Vaccine Sales YoY (2021-2032) & (M Doses) Figure 29. Asia (Excluding China) Human Vaccine Sales YoY (2021-2032) & (M Doses) Figure 30. South America, Middle East and Africa Human Vaccine Sales YoY (2021-2032) & (M Doses) Figure 31. Global Human Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Human Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Human Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Human Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Human Vaccine Revenue Market Share by Type (2021-2032) Figure 37. Global Human Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 38. Global Human Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Human Vaccine Sales Market Share by Type (2021-2032) Figure 40. Global Human Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Human Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Human Vaccine Revenue Market Share by Application (2021-2032) Figure 43. Global Human Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 44. Global Human Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Human Vaccine Sales Market Share by Application (2021-2032) Figure 46. North America Human Vaccine Revenue Share by Type (2021-2032) Figure 47. North America Human Vaccine Sales Share by Type (2021-2032) Figure 48. North America Human Vaccine Revenue Share by Application (2021-2032) Figure 49. North America Human Vaccine Sales Share by Application (2021-2032) Figure 50. North America Human Vaccine Revenue Share by Country (2021-2032) Figure 51. North America Human Vaccine Sales Share by Country (2021-2032) Figure 52. Europe Human Vaccine Revenue Share by Type (2021-2032) Figure 53. Europe Human Vaccine Sales Share by Type (2021-2032) Figure 54. Europe Human Vaccine Revenue Share by Application (2021-2032) Figure 55. Europe Human Vaccine Sales Share by Application (2021-2032) Figure 56. Europe Human Vaccine Revenue Share by Country (2021-2032) Figure 57. Europe Human Vaccine Sales Share by Country (2021-2032) Figure 58. China Human Vaccine Revenue Share by Type (2021-2032) Figure 59. China Human Vaccine Sales Share by Type (2021-2032) Figure 60. China Human Vaccine Revenue Share by Application (2021-2032) Figure 61. China Human Vaccine Sales Share by Application (2021-2032) Figure 62. Asia Human Vaccine Revenue Share by Type (2021-2032) Figure 63. Asia Human Vaccine Sales Share by Type (2021-2032) Figure 64. Asia Human Vaccine Revenue Share by Application (2021-2032) Figure 65. Asia Human Vaccine Sales Share by Application (2021-2032) Figure 66. Asia Human Vaccine Revenue Share by Country (2021-2032) Figure 67. Asia Human Vaccine Sales Share by Country (2021-2032) Figure 68. SAMEA Human Vaccine Revenue Share by Type (2021-2032) Figure 69. SAMEA Human Vaccine Sales Share by Type (2021-2032) Figure 70. SAMEA Human Vaccine Revenue Share by Application (2021-2032) Figure 71. SAMEA Human Vaccine Sales Share by Application (2021-2032) Figure 72. SAMEA Human Vaccine Revenue Share by Country (2021-2032) Figure 73. SAMEA Human Vaccine Sales Share by Country (2021-2032) Figure 74. Human Vaccine Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Human Vaccine Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Varicella
  • Influenza
  • Polio
  • Hepatitis A
  • Rabies
  • BCG
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Rota vaccine
Applications
  • Adults
  • Children
Companies covered
  • CNBG
  • Changsheng Life
  • Zhifei
  • ChengDa Bio
  • Kangtai
  • SINOVAC BIOTECH
  • Hissen
  • Walvax Biotechnology
  • GSK
  • SANOFI
  • Rong An
  • NuoCheng Bio
  • Hualan Bio
  • Tiantan biological
  • Changchun Baike
  • Adimmune
  • Zhongyianke Biotech
  • Bharat Biotech
  • Bavarian Nordic
  • Sanofi-Pasteur
  • Indian Immunologicals
  • KANGH
  • Henan Grand Biopharma
  • ZhongKe Biopharm
  • Zhuoyi Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Vaccine Market by Type
  3. 1.2.1 Global Human Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Varicella
  5. 1.2.3 Influenza
  6. 1.2.4 Polio
  7. 1.2.5 Hepatitis A
  8. 1.2.6 Rabies
  9. 1.2.7 BCG
  10. 1.2.8 Hepatitis B
  11. 1.2.9 Pertussis, Diphtheria, Tetanus
  12. 1.2.10 Pneumococcal
  13. 1.2.11 Rota vaccine
  14. 1.3 Human Vaccine Market by Application
  15. 1.3.1 Global Human Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  16. 1.3.2 Adults
  17. 1.3.3 Children
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Human Vaccine Market Dynamics
  1. 2.1 Human Vaccine Industry Trends
  2. 2.2 Human Vaccine Industry Drivers
  3. 2.3 Human Vaccine Industry Opportunities and Challenges
  4. 2.4 Human Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Vaccine Revenue by Region
  3. 3.2.1 Global Human Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Vaccine Sales by Region
  9. 3.4.1 Global Human Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Human Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Human Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Human Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Vaccine Sales by Manufacturers
  6. 4.2.1 Global Human Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Human Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Human Vaccine Tier 1, Tier 2, and Tier 3
5 Human Vaccine Market by Type
  1. 5.1 Global Human Vaccine Revenue by Type
  2. 5.1.1 Global Human Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Vaccine Sales by Type
  6. 5.2.1 Global Human Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Vaccine Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Human Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Vaccine Price by Type
6 Human Vaccine Market by Application
  1. 6.1 Global Human Vaccine Revenue by Application
  2. 6.1.1 Global Human Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Vaccine Sales by Application
  6. 6.2.1 Global Human Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Vaccine Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Human Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Vaccine Price by Application
7 Company Profiles
  1. 7.1 CNBG
  2. 7.1.1 CNBG Company Information
  3. 7.1.2 CNBG Business Overview
  4. 7.1.3 CNBG Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CNBG Human Vaccine Product Portfolio
  6. 7.1.5 CNBG Recent Developments
  7. 7.2 Changsheng Life
  8. 7.2.1 Changsheng Life Company Information
  9. 7.2.2 Changsheng Life Business Overview
  10. 7.2.3 Changsheng Life Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Changsheng Life Human Vaccine Product Portfolio
  12. 7.2.5 Changsheng Life Recent Developments
  13. 7.3 Zhifei
  14. 7.3.1 Zhifei Company Information
  15. 7.3.2 Zhifei Business Overview
  16. 7.3.3 Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zhifei Human Vaccine Product Portfolio
  18. 7.3.5 Zhifei Recent Developments
  19. 7.4 ChengDa Bio
  20. 7.4.1 ChengDa Bio Company Information
  21. 7.4.2 ChengDa Bio Business Overview
  22. 7.4.3 ChengDa Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 ChengDa Bio Human Vaccine Product Portfolio
  24. 7.4.5 ChengDa Bio Recent Developments
  25. 7.5 Kangtai
  26. 7.5.1 Kangtai Company Information
  27. 7.5.2 Kangtai Business Overview
  28. 7.5.3 Kangtai Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Kangtai Human Vaccine Product Portfolio
  30. 7.5.5 Kangtai Recent Developments
  31. 7.6 SINOVAC BIOTECH
  32. 7.6.1 SINOVAC BIOTECH Company Information
  33. 7.6.2 SINOVAC BIOTECH Business Overview
  34. 7.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 SINOVAC BIOTECH Human Vaccine Product Portfolio
  36. 7.6.5 SINOVAC BIOTECH Recent Developments
  37. 7.7 Hissen
  38. 7.7.1 Hissen Company Information
  39. 7.7.2 Hissen Business Overview
  40. 7.7.3 Hissen Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hissen Human Vaccine Product Portfolio
  42. 7.7.5 Hissen Recent Developments
  43. 7.8 Walvax Biotechnology
  44. 7.8.1 Walvax Biotechnology Company Information
  45. 7.8.2 Walvax Biotechnology Business Overview
  46. 7.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Walvax Biotechnology Human Vaccine Product Portfolio
  48. 7.8.5 Walvax Biotechnology Recent Developments
  49. 7.9 GSK
  50. 7.9.1 GSK Company Information
  51. 7.9.2 GSK Business Overview
  52. 7.9.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GSK Human Vaccine Product Portfolio
  54. 7.9.5 GSK Recent Developments
  55. 7.10 SANOFI
  56. 7.10.1 SANOFI Company Information
  57. 7.10.2 SANOFI Business Overview
  58. 7.10.3 SANOFI Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 SANOFI Human Vaccine Product Portfolio
  60. 7.10.5 SANOFI Recent Developments
  61. 7.11 Rong An
  62. 7.11.1 Rong An Company Information
  63. 7.11.2 Rong An Business Overview
  64. 7.11.3 Rong An Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Rong An Human Vaccine Product Portfolio
  66. 7.11.5 Rong An Recent Developments
  67. 7.12 NuoCheng Bio
  68. 7.12.1 NuoCheng Bio Company Information
  69. 7.12.2 NuoCheng Bio Business Overview
  70. 7.12.3 NuoCheng Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 NuoCheng Bio Human Vaccine Product Portfolio
  72. 7.12.5 NuoCheng Bio Recent Developments
  73. 7.13 Hualan Bio
  74. 7.13.1 Hualan Bio Company Information
  75. 7.13.2 Hualan Bio Business Overview
  76. 7.13.3 Hualan Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hualan Bio Human Vaccine Product Portfolio
  78. 7.13.5 Hualan Bio Recent Developments
  79. 7.14 Tiantan biological
  80. 7.14.1 Tiantan biological Company Information
  81. 7.14.2 Tiantan biological Business Overview
  82. 7.14.3 Tiantan biological Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Tiantan biological Human Vaccine Product Portfolio
  84. 7.14.5 Tiantan biological Recent Developments
  85. 7.15 Changchun Baike
  86. 7.15.1 Changchun Baike Company Information
  87. 7.15.2 Changchun Baike Business Overview
  88. 7.15.3 Changchun Baike Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Changchun Baike Human Vaccine Product Portfolio
  90. 7.15.5 Changchun Baike Recent Developments
  91. 7.16 Adimmune
  92. 7.16.1 Adimmune Company Information
  93. 7.16.2 Adimmune Business Overview
  94. 7.16.3 Adimmune Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Adimmune Human Vaccine Product Portfolio
  96. 7.16.5 Adimmune Recent Developments
  97. 7.17 Zhongyianke Biotech
  98. 7.17.1 Zhongyianke Biotech Company Information
  99. 7.17.2 Zhongyianke Biotech Business Overview
  100. 7.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Zhongyianke Biotech Human Vaccine Product Portfolio
  102. 7.17.5 Zhongyianke Biotech Recent Developments
  103. 7.18 Bharat Biotech
  104. 7.18.1 Bharat Biotech Company Information
  105. 7.18.2 Bharat Biotech Business Overview
  106. 7.18.3 Bharat Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Bharat Biotech Human Vaccine Product Portfolio
  108. 7.18.5 Bharat Biotech Recent Developments
  109. 7.19 Bavarian Nordic
  110. 7.19.1 Bavarian Nordic Company Information
  111. 7.19.2 Bavarian Nordic Business Overview
  112. 7.19.3 Bavarian Nordic Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Bavarian Nordic Human Vaccine Product Portfolio
  114. 7.19.5 Bavarian Nordic Recent Developments
  115. 7.20 Sanofi-Pasteur
  116. 7.20.1 Sanofi-Pasteur Company Information
  117. 7.20.2 Sanofi-Pasteur Business Overview
  118. 7.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Sanofi-Pasteur Human Vaccine Product Portfolio
  120. 7.20.5 Sanofi-Pasteur Recent Developments
  121. 7.21 Indian Immunologicals
  122. 7.21.1 Indian Immunologicals Company Information
  123. 7.21.2 Indian Immunologicals Business Overview
  124. 7.21.3 Indian Immunologicals Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Indian Immunologicals Human Vaccine Product Portfolio
  126. 7.21.5 Indian Immunologicals Recent Developments
  127. 7.22 KANGH
  128. 7.22.1 KANGH Company Information
  129. 7.22.2 KANGH Business Overview
  130. 7.22.3 KANGH Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 KANGH Human Vaccine Product Portfolio
  132. 7.22.5 KANGH Recent Developments
  133. 7.23 Henan Grand Biopharma
  134. 7.23.1 Henan Grand Biopharma Company Information
  135. 7.23.2 Henan Grand Biopharma Business Overview
  136. 7.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Henan Grand Biopharma Human Vaccine Product Portfolio
  138. 7.23.5 Henan Grand Biopharma Recent Developments
  139. 7.24 ZhongKe Biopharm
  140. 7.24.1 ZhongKe Biopharm Company Information
  141. 7.24.2 ZhongKe Biopharm Business Overview
  142. 7.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 ZhongKe Biopharm Human Vaccine Product Portfolio
  144. 7.24.5 ZhongKe Biopharm Recent Developments
  145. 7.25 Zhuoyi Biological
  146. 7.25.1 Zhuoyi Biological Company Information
  147. 7.25.2 Zhuoyi Biological Business Overview
  148. 7.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Zhuoyi Biological Human Vaccine Product Portfolio
  150. 7.25.5 Zhuoyi Biological Recent Developments
8 North America
  1. 8.1 North America Human Vaccine Market Size by Type
  2. 8.1.1 North America Human Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Human Vaccine Price by Type (2021-2032)
  5. 8.2 North America Human Vaccine Market Size by Application
  6. 8.2.1 North America Human Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Human Vaccine Price by Application (2021-2032)
  9. 8.3 North America Human Vaccine Market Size by Country
  10. 8.3.1 North America Human Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Vaccine Market Size by Type
  2. 9.1.1 Europe Human Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Human Vaccine Market Size by Application
  6. 9.2.1 Europe Human Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Human Vaccine Market Size by Country
  10. 9.3.1 Europe Human Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Vaccine Market Size by Type
  2. 10.1.1 China Human Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Human Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Human Vaccine Price by Type (2021-2032)
  5. 10.2 China Human Vaccine Market Size by Application
  6. 10.2.1 China Human Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Human Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Human Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Vaccine Market Size by Type
  2. 11.1.1 Asia Human Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Human Vaccine Market Size by Application
  6. 11.2.1 Asia Human Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Human Vaccine Market Size by Country
  10. 11.3.1 Asia Human Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Vaccine Market Size by Type
  2. 12.1.1 SAMEA Human Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Human Vaccine Market Size by Application
  6. 12.2.1 SAMEA Human Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Human Vaccine Market Size by Country
  10. 12.3.1 SAMEA Human Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Vaccine Value Chain Analysis
  2. 13.1.1 Human Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Vaccine Production Mode & Process
  6. 13.2 Human Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Vaccine Distributors
  9. 13.2.3 Human Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst